255 related articles for article (PubMed ID: 8724857)
1. Antibody responses to Epstein-Barr virus, human herpesvirus 6 and human herpesvirus 7 in patients with chronic fatigue syndrome.
Sairenji T; Yamanishi K; Tachibana Y; Bertoni G; Kurata T
Intervirology; 1995; 38(5):269-73. PubMed ID: 8724857
[TBL] [Abstract][Full Text] [Related]
2. Cytomegalovirus, Epstein-Barr virus, and human herpesvirus-6 infections in patients with myalgic еncephalomyelitis/chronic fatigue syndrome.
Shikova E; Reshkova V; Kumanova А; Raleva S; Alexandrova D; Capo N; Murovska M; On Behalf Of The European Network On Me/Cfs Euromene
J Med Virol; 2020 Dec; 92(12):3682-3688. PubMed ID: 32129496
[TBL] [Abstract][Full Text] [Related]
3. Serological and virological investigation of the role of the herpesviruses EBV, CMV and HHV-6 in post-infective fatigue syndrome.
Cameron B; Flamand L; Juwana H; Middeldorp J; Naing Z; Rawlinson W; Ablashi D; Lloyd A
J Med Virol; 2010 Oct; 82(10):1684-8. PubMed ID: 20827765
[TBL] [Abstract][Full Text] [Related]
4. Response to valganciclovir in chronic fatigue syndrome patients with human herpesvirus 6 and Epstein-Barr virus IgG antibody titers.
Watt T; Oberfoell S; Balise R; Lunn MR; Kar AK; Merrihew L; Bhangoo MS; Montoya JG
J Med Virol; 2012 Dec; 84(12):1967-74. PubMed ID: 23080504
[TBL] [Abstract][Full Text] [Related]
5. Simultaneous measurement of antibodies to Epstein-Barr virus, human herpesvirus 6, herpes simplex virus types 1 and 2, and 14 enteroviruses in chronic fatigue syndrome: is there evidence of activation of a nonspecific polyclonal immune response?
Manian FA
Clin Infect Dis; 1994 Sep; 19(3):448-53. PubMed ID: 7811864
[TBL] [Abstract][Full Text] [Related]
6. Antibodies to Human Herpesviruses in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Patients.
Blomberg J; Rizwan M; Böhlin-Wiener A; Elfaitouri A; Julin P; Zachrisson O; Rosén A; Gottfries CG
Front Immunol; 2019; 10():1946. PubMed ID: 31475007
[TBL] [Abstract][Full Text] [Related]
7. Human herpesviruses in chronic fatigue syndrome.
Wallace HL; Natelson B; Gause W; Hay J
Clin Diagn Lab Immunol; 1999 Mar; 6(2):216-23. PubMed ID: 10066657
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of IgM antibodies to human herpesvirus 6 early antigen (p41/38) in patients with chronic fatigue syndrome.
Patnaik M; Komaroff AL; Conley E; Ojo-Amaize EA; Peter JB
J Infect Dis; 1995 Nov; 172(5):1364-7. PubMed ID: 7594679
[TBL] [Abstract][Full Text] [Related]
9. Human endogenous retrovirus-K18 superantigen expression and human herpesvirus-6 and human herpesvirus-7 viral loads in chronic fatigue patients.
Oakes B; Hoagland-Henefield M; Komaroff AL; Erickson JL; Huber BT
Clin Infect Dis; 2013 May; 56(10):1394-400. PubMed ID: 23408682
[TBL] [Abstract][Full Text] [Related]
10. Activation of human herpesviruses 6 and 7 in patients with chronic fatigue syndrome.
Chapenko S; Krumina A; Kozireva S; Nora Z; Sultanova A; Viksna L; Murovska M
J Clin Virol; 2006 Dec; 37 Suppl 1():S47-51. PubMed ID: 17276369
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of antibodies to the Epstein-Barr virus immediate early gene product ZEBRA by a new enzyme-linked immunosorbent assay.
Yamauchi Y; Tachiband Y; Maeda A; Wakiguchi H; Usui M; Kurata T; Sairenji T
Intervirology; 1998; 41(6):278-84. PubMed ID: 10325538
[TBL] [Abstract][Full Text] [Related]
12. Reactivation of human herpesvirus (HHV) family members other than HHV-6 in drug-induced hypersensitivity syndrome.
Seishima M; Yamanaka S; Fujisawa T; Tohyama M; Hashimoto K
Br J Dermatol; 2006 Aug; 155(2):344-9. PubMed ID: 16882173
[TBL] [Abstract][Full Text] [Related]
13. The disease associations of the antibody response against the Epstein-Barr virus transactivator protein ZEBRA can be separated into different epitopes.
Tedeschi R; Foong YT; Cheng HM; dePaoli P; Lehtinen T; Elfborg T; Dillner J
J Gen Virol; 1995 Jun; 76 ( Pt 6)():1393-400. PubMed ID: 7540196
[TBL] [Abstract][Full Text] [Related]
14. Frequent double infection with Epstein-Barr virus and human herpesvirus-6 in patients with acute infectious mononucleosis.
Bertram G; Dreiner N; Krueger GR; Ramon A; Ablashi DV; Salahuddin SZ; Balachandram N
In Vivo; 1991; 5(3):271-9. PubMed ID: 1654150
[TBL] [Abstract][Full Text] [Related]
15. Human herpesvirus 6 and human herpesvirus 7 in chronic fatigue syndrome.
Di Luca D; Zorzenon M; Mirandola P; Colle R; Botta GA; Cassai E
J Clin Microbiol; 1995 Jun; 33(6):1660-61. PubMed ID: 7650209
[TBL] [Abstract][Full Text] [Related]
16. Use of valganciclovir in patients with elevated antibody titers against Human Herpesvirus-6 (HHV-6) and Epstein-Barr Virus (EBV) who were experiencing central nervous system dysfunction including long-standing fatigue.
Kogelnik AM; Loomis K; Hoegh-Petersen M; Rosso F; Hischier C; Montoya JG
J Clin Virol; 2006 Dec; 37 Suppl 1():S33-8. PubMed ID: 17276366
[TBL] [Abstract][Full Text] [Related]
17. Human herpesviruses 6 and 7 in chronic fatigue syndrome: a case-control study.
Reeves WC; Stamey FR; Black JB; Mawle AC; Stewart JA; Pellett PE
Clin Infect Dis; 2000 Jul; 31(1):48-52. PubMed ID: 10913395
[TBL] [Abstract][Full Text] [Related]
18. Frequent HHV-6 reactivation in multiple sclerosis (MS) and chronic fatigue syndrome (CFS) patients.
Ablashi DV; Eastman HB; Owen CB; Roman MM; Friedman J; Zabriskie JB; Peterson DL; Pearson GR; Whitman JE
J Clin Virol; 2000 May; 16(3):179-91. PubMed ID: 10738137
[TBL] [Abstract][Full Text] [Related]
19. IgM serum antibodies to Epstein-Barr virus are uniquely present in a subset of patients with the chronic fatigue syndrome.
Lerner AM; Beqaj SH; Deeter RG; Fitzgerald JT
In Vivo; 2004; 18(2):101-6. PubMed ID: 15113035
[TBL] [Abstract][Full Text] [Related]
20. Reactivation of herpesvirus type 6 and IgA/IgM-mediated responses to activin-A underpin long COVID, including affective symptoms and chronic fatigue syndrome.
Vojdani A; Almulla AF; Zhou B; Al-Hakeim HK; Maes M
Acta Neuropsychiatr; 2024 Jun; 36(3):172-184. PubMed ID: 38571295
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]